FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2979510114> ?p ?o ?g. }

• W2979510114 abstract "Abstract Growth under hypoxic conditions can lead to resistance to a variety of cell death stimuli in cancer cells. Bone marrow (BM) has less vasculature than other organs, and the rapid growth of leukemic cells in BM frequently outpaces the oxygen supply. Thus, adaptation to hypoxia may be critical to the survival and proliferation of leukemic cells. However, the role of hypoxia in the treatment of leukemia has received little attention. We hypothesized that leukemic cells acquire drug resistance by adapting to hypoxia in the BM, and that identifying the underlying molecular mechanisms for this adaptation would reveal new approaches to the development of new therapeutic targets in drug- resistant leukemia cells. To test this hypothesis, we cultured five chronic myelogenous leukemia (CML)-derived cell lines (BV173, K562, KCL22, KT-1, and MYL) continuously in 1.0% oxygen. Among them, hypoxia resistant (HR) subclones of K562 and KCL22 cells (K562/HR and KCL22/HR) were selected under 1.0% oxygen conditions, and these cells were able to grow for several months and to be suspended in RPMI1640 plus 10% FCS without any additional nutrients, although their growth rate was slower than parental cells in 20% oxygen. Both K562/HR and KCL22/HR cells produced less ATP (78% and 92%, respectively), perhaps due to impairment of the oxygen-dependent energy production pathway, and HR cells showed higher expression and enhanced kinetics of glyoxalase-I (Glo-I), a detoxification kinase of methylglyoxal (a cytotoxic byproduct of glycolysis), compared to parental cells. Glo-I has previously been implicated in drug resistance in cancer, including leukemia. Autophosphorylation of Bcr-Abl was reduced in HR cell lines, while the phosphorylation status of the downstream signalling molecules Akt and Stat5 was unchanged, which suggests that there are alternative, hypoxia-specific activators of these pathways. K562/HR and KCL22/HR cells were less sensitive to chemotherapeutic agents such as the Bcr-Abl tyrosine kinase (TK) inhibitors imatinib, dasatinib, nilotinib, and INNO-406, and the alkylating agents daunorucbicin and busulfan. In contrast, K562/HR and KCL22/HR cells were more sensitive to cell death induced by a Glo-I inhibitor, COTC, compared to parental cells. These results indicated that Glo-I plays an important role in survival under hypoxic conditions, and that Glo- I may be an alternative molecular target in CML cells that have acquired resistance to conventional chemotherapeutics through adaptating to hypoxia." @default.
• W2979510114 created "2019-10-18" @default.
• W2979510114 creator A5006523921 @default.
• W2979510114 creator A5018005698 @default.
• W2979510114 creator A5024882304 @default.
• W2979510114 creator A5025614828 @default.
• W2979510114 creator A5027165443 @default.
• W2979510114 creator A5035319682 @default.
• W2979510114 creator A5036112859 @default.
• W2979510114 creator A5039456378 @default.
• W2979510114 creator A5043802441 @default.
• W2979510114 creator A5068027963 @default.
• W2979510114 creator A5071371446 @default.
• W2979510114 date "2007-11-16" @default.
• W2979510114 modified "2023-09-28" @default.
• W2979510114 title "Glyoxalase-I Is a Potential Therapeutic Target for Chronic Myelogenous Leukemia Cells That Have Acquired Drug Resistance through Adaptation to Hypoxia." @default.
• W2979510114 doi "https://doi.org/10.1182/blood.v110.11.2931.2931" @default.
• W2979510114 hasPublicationYear "2007" @default.
• W2979510114 type Work @default.
• W2979510114 sameAs 2979510114 @default.
• W2979510114 citedByCount "0" @default.
• W2979510114 crossrefType "journal-article" @default.
• W2979510114 hasAuthorship W2979510114A5006523921 @default.
• W2979510114 hasAuthorship W2979510114A5018005698 @default.
• W2979510114 hasAuthorship W2979510114A5024882304 @default.
• W2979510114 hasAuthorship W2979510114A5025614828 @default.
• W2979510114 hasAuthorship W2979510114A5027165443 @default.
• W2979510114 hasAuthorship W2979510114A5035319682 @default.
• W2979510114 hasAuthorship W2979510114A5036112859 @default.
• W2979510114 hasAuthorship W2979510114A5039456378 @default.
• W2979510114 hasAuthorship W2979510114A5043802441 @default.
• W2979510114 hasAuthorship W2979510114A5068027963 @default.
• W2979510114 hasAuthorship W2979510114A5071371446 @default.
• W2979510114 hasConcept C121608353 @default.
• W2979510114 hasConcept C171122931 @default.
• W2979510114 hasConcept C178790620 @default.
• W2979510114 hasConcept C185592680 @default.
• W2979510114 hasConcept C203014093 @default.
• W2979510114 hasConcept C2776960273 @default.
• W2979510114 hasConcept C2778461978 @default.
• W2979510114 hasConcept C2780007613 @default.
• W2979510114 hasConcept C502942594 @default.
• W2979510114 hasConcept C540031477 @default.
• W2979510114 hasConcept C54355233 @default.
• W2979510114 hasConcept C7836513 @default.
• W2979510114 hasConcept C86803240 @default.
• W2979510114 hasConcept C96232424 @default.
• W2979510114 hasConcept C98274493 @default.
• W2979510114 hasConceptScore W2979510114C121608353 @default.
• W2979510114 hasConceptScore W2979510114C171122931 @default.
• W2979510114 hasConceptScore W2979510114C178790620 @default.
• W2979510114 hasConceptScore W2979510114C185592680 @default.
• W2979510114 hasConceptScore W2979510114C203014093 @default.
• W2979510114 hasConceptScore W2979510114C2776960273 @default.
• W2979510114 hasConceptScore W2979510114C2778461978 @default.
• W2979510114 hasConceptScore W2979510114C2780007613 @default.
• W2979510114 hasConceptScore W2979510114C502942594 @default.
• W2979510114 hasConceptScore W2979510114C540031477 @default.
• W2979510114 hasConceptScore W2979510114C54355233 @default.
• W2979510114 hasConceptScore W2979510114C7836513 @default.
• W2979510114 hasConceptScore W2979510114C86803240 @default.
• W2979510114 hasConceptScore W2979510114C96232424 @default.
• W2979510114 hasConceptScore W2979510114C98274493 @default.
• W2979510114 hasLocation W29795101141 @default.
• W2979510114 hasOpenAccess W2979510114 @default.
• W2979510114 hasPrimaryLocation W29795101141 @default.
• W2979510114 hasRelatedWork W1978071048 @default.
• W2979510114 hasRelatedWork W2005372647 @default.
• W2979510114 hasRelatedWork W2074619256 @default.
• W2979510114 hasRelatedWork W2124344974 @default.
• W2979510114 hasRelatedWork W2136658115 @default.
• W2979510114 hasRelatedWork W2360877485 @default.
• W2979510114 hasRelatedWork W2366088680 @default.
• W2979510114 hasRelatedWork W2372087098 @default.
• W2979510114 hasRelatedWork W2592135847 @default.
• W2979510114 hasRelatedWork W3155570094 @default.
• W2979510114 isParatext "false" @default.
• W2979510114 isRetracted "false" @default.
• W2979510114 magId "2979510114" @default.
• W2979510114 workType "article" @default.